ARCHIVES

Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Wynder’s Low Fat Adjuvant Breast Cancer Study Finally Funded

October 21, 1988

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

News Analysis: Industry’s Accelerated Recovery Initiative May Push Manufacturers Toward Collusion

October 5, 2012

In Congress: $135 Million Expected For DOD Breast Cancer Research Program

July 24, 1998

Clinical Trials Approved By NCI CTEP Last Month

December 31, 2010